Connect with NCQA

twitter linkedin facebook google+ youtube pinterest

Report an Error

Use NCQA’s Feedback Form to report a broken link, or content error.

Adherence to Antipsychotic Medications for People with Schizophrenia

This HEDIS Measure

Assesses adults 19–64 years of age who have schizophrenia and were dispensed and remained on an antipsychotic medication for at least 80 percent of their treatment period.

So What?

Schizophrenia is a chronic and disabling psychiatric disorder that requires ongoing treatment and monitoring. Symptoms include hallucinations, illogical thinking, memory impairment, and incoherent speech.1 Medication non-adherence is common and a major concern in the treatment of schizophrenia. Using antipsychotic medications as prescribed reduces the risk of relapse or hospitalization.2

References

  1. American Psychiatric Association. Schizophrenia Fact Sheet. http://www.dsm5.org/Documents/Schizophrenia%20Fact%20Sheet.pdf.
  2. Busch, A. B., Lehman, A. F., Goldman, H., & Frank, R. G. (2009). Changes over time and disparities in schizophrenia treatment quality. Med Care, 47(2), 199-207.
tables
Adherence to Antipsychotic Medications for Individuals With Schizophrenia
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016 _ _ 59.2 _ _
2015 _ _ 58.0 _ _
2014 60.1
2013 60.1